Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Genprex Inc (NQ: GNPX )

3.370 USD +0.030 (+0.90%)
Streaming Delayed Price Updated: 12:06 PM EST, Dec 3, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Genprex Inc

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Genprex to Present at the Benzinga Global Small Cap Conference on December 8
Genprex's President and CEO will present at the Benzinga Conference on Dec. 8, 2020 at 2:30 p.m. ET 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Commences Site Recruitment for Upcoming Acclaim-1 Clinical Trial
From InvestorBrandNetwork
Genprex Initiates Site Recruitment for Acclaim-1 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer
Genprex commences clinical trial site recruitment for Acclaim-1 clinical trial 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Diamond Equity Research Emerging Growth Invitational
From InvestorBrandNetwork
Diamond Equity Research 2020 Virtual Emerging Growth Invitational
From ACCESSWIRE
Genprex to Participate at the Diamond Equity Research Emerging Growth Invitational on December 1
Genprex's COO will present on December 1 at the Diamond Equity Research Emerging Growth Invitational 
From Business Wire News Releases
Analysts See 25% Gains Ahead For The Holdings of FDM
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
InvestorNewsBreaks – Benzinga Launches Global Small Cap Conference Series; First Event Slated for December
From InvestorBrandNetwork
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Participate in Life Sciences Summit Panel
From InvestorBrandNetwork
Genprex to Participate in Panel at Life Sciences Summit on November 17
Genprex's Thomas Gallagher will participate as a panelist at the NYC-based Life Sciences Summit 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Expands Scientific Advisory Board with Strategic Appointment
From InvestorBrandNetwork
Genprex Strengthens Scientific Advisory Board with Appointment of Lead Researcher of University of Pittsburgh, George K. Gittes, MD
George Gittes, MD Joins Genprex's Scientific Advisory Board 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Launch of New Branding for Upcoming Combination Clinical Trials
From InvestorBrandNetwork
Genprex Unveils New Branding for Upcoming Combination Clinical Trials in Non-Small Cell Lung Cancer
Genprex announces new clinical trial branding for upcoming trials in non-small cell lung cancer 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Conditional FDA Acceptance of Proprietary Name for Lead Drug Candidate
From InvestorBrandNetwork
Genprex Receives Conditional FDA Acceptance of Proprietary Name REQORSA™ for Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer
Genprex receives conditional FDA acceptance of proprietary name Reqorsa(TM) for lead drug candidate 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Appoints Eric Chapdelaine to Senior Manufacturing Team
From InvestorBrandNetwork
Genprex Promotes Eric Chapdelaine to Vice President of Manufacturing
Genprex appoints Eric Chapdelaine to VP of Manufacturing 
From Business Wire News Releases
First Week of June 2021 Options Trading For Genprex (GNPX)
Investors in Genprex Inc (GNPX) saw new options become available this week, for the June 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time... 
Tags Stocks
From Market News Video
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) CEO Scheduled to Present at LD Micro Event
From InvestorBrandNetwork
Genprex to Present at Zooming with LD Micro on October 14, 2020
Genprex will present at the Zooming with LD Micro virtual event 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Cell and Gene Therapy Sector’s Foremost Annual Conference
From InvestorBrandNetwork
Genprex to Present at the Alliance for Regenerative Medicine’s Virtual Cell and Gene Meeting on the Mesa
Genprex will present at the Cell and Gene Meeting on the Mesa 
From Business Wire News Releases
BioMedNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Appoints Seasoned Biotech Executive to Advance Expanding IP Estate
From InvestorBrandNetwork
Genprex Names Seasoned IP Executive, Thomas C. Gallagher, as Senior Vice President of Intellectual Property and Licensing
Genprex hires Senior Vice President of IP and Licensing 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Appoints New VP to Oversee Regulatory Affairs
From InvestorBrandNetwork
Genprex Appoints William E. Gannon, Jr., MD, MBA, as Vice President of Regulatory Affairs
Genprex appoints new Vice President of Regulatory Affairs 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Invited to Present at Prestigious LD 500 Virtual Investor Conference
From InvestorBrandNetwork
Genprex to Present at The LD 500 Virtual Conference
Genprex's Chairman and CEO will present on September 1, 2020 at the LD 500 Virtual Conference 
From Business Wire News Releases
81 Biggest Movers From Friday
Gainers CureVac N.V. (NASDAQ: CVAC) shares jumped 249.4% to close at $55.90 on Friday after the company priced its IPO at $16 per ... 
Tags Integrated Telecommunication Services EFOI Top Gainers
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.